Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

Nov 23, 2015

30071_dirs_2015-11-23_bb2e83ee-1986-40a6-b623-655d0872c9e0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-19

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-19 ResMed Common Stock A 2180 Acquired 109610 Direct
2015-11-20 ResMed Common Stock S 12000 $59.0317 Disposed 323900 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-19 ResMed Common Stock Options $58.24 A 10246 Acquired 2022-11-19 ResMed Common Stock (10.246) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 136000 Indirect
ResMed Common Stock 23200 Indirect

Footnotes

F1: Shares awarded are restricted stock units. The RSUs cliff vest on the earlier of November 11, 2016, or the annual shareholder's meeting in the year following the grant date.

F2: Options vest in full (I) on the first Nov. 11 following the grant date or (ii) the first annual shareholder's meeting following grant date.